| Net Sales | 5.3B |
| Cost of products sold | 2.29B |
| Research and development | 352M |
| Acquired in-process research and development | |
| Selling, general and administrative | 1.63B |
| Total Operating Cost and Expenses | 4.41B |
| Operating Earnings | 897M |
| Interest expense | 117M |
| Interest (income) | -22M |
| Net foreign exchange loss (gain) | 9M |
| Other (income) expense, net | 972M |
| Earnings Before Taxes | |
| Taxes on Earnings | 178M |
| Net Earnings | |
| Basic Earnings Per Common Share (in dollars per share) | -0.22 |
| Diluted Earnings Per Common Share (in dollars per share) | -0.22 |
| Cash Dividends Declared Per Common Share (in dollars per share) | 0.26 |
| Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares) | 1.48B |
| Dilutive Common Stock Options and Awards (in shares) | 0 |
| Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options and Awards (in shares) | 1.48B |
| Outstanding Common Stock Options Having No Dilutive Effect (in shares) | 12.1M |